Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results

Go back to Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results
POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 17.95 -0.11 (0.61%)
Previous Close $18.06    52 Week High $11.63 
Open $18.01    52 Week Low $9.19 
Day High $18.08    P/E N/A 
Day Low $17.91    EPS $0.00 
Volume 23,813       

POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 17.95 -0.11 (0.61%)
Previous Close $18.06    52 Week High $11.63 
Open $18.01    52 Week Low $9.19 
Day High $18.08    P/E N/A 
Day Low $17.91    EPS $0.00 
Volume 23,813       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.48 +0.08 (3.33%)
Previous Close $2.40    52 Week High $1.11 
Open $2.39    52 Week Low $0.41 
Day High $2.48    P/E N/A 
Day Low $2.36    EPS $-0.29 
Volume 1,023,783       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.48 +0.08 (3.33%)
Previous Close $2.40    52 Week High $1.11 
Open $2.39    52 Week Low $0.41 
Day High $2.48    P/E N/A 
Day Low $2.36    EPS $-0.29 
Volume 1,023,783